IP Library Granted Patent US 7,902,345
Granted Patent B2
US 7,902,345 · App. 12/133,327 · Granted Mar 8, 2011

Detection and quantification of biomolecules using mass spectrometry

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,902,345
App. No.
12/133,327
Granted
Mar 8, 2011
Kind
B2
Abstract

The present invention is directed in part to a method for detecting a target nucleic acid using detector oligonucleotides detectable by mass spectrometry. This method takes advantage of the 5′ to 3′ nuclease activity of a nucleic acid polymerase to cleave annealed oligonucleotide probes from hybridized duplexes and releases labels for detection by mass spectrometry. This process is easily incorporated into a polymerase chain reaction (PCR) amplification assay. The method also includes embodiments directed to quantitative analysis of target nucleic acids.

Claims (17)

1. A detector oligonucleotide comprising a complementary portion that is complementary to a target nucleic acid, and a non-complementary portion that is susceptible to cleavage by a cleavage agent, thereby producing a mass distinguishable product (MDP), wherein the detector oligonucleotide comprises a capture mechanism in the detector oligonucleotide on the non-complementary portion that allows for the mass-distinguishable product to bind to a solid support upon its cleavage from the detector oligonucleotide by the cleavage agent.

2. The detector oligonucleotide of claim 1 , further comprising a modification that increases the melting temperature of the detector oligonucleotide.

3. The detector oligonucleotide of claim 1 , further comprising a modification that increases resistance of the detector oligonucleotide to cleavage.

4. The detector oligonucleotide of claim 2 , wherein the complementary portion comprises a modification that increases the melting temperature of the detector oligonucleotide.

5. The detector oligonucleotide of claim 4 , wherein the modification is the incorporation of one or more minor groove binders to the detector oligonucleotide.

6. The detector oligonucleotide of claim 3 , wherein the complementary portion comprises a modification that increases resistance of the detector oligonucleotide to cleavage.

7. The detector oligonucleotide of claim 6 , wherein the modification is the incorporation of one or more locked nucleic acids (LNAs) or amadites.

8. The detector oligonucleotide of claim 1 , wherein the capture mechanism is a biotin molecule.

9. The detector oligonucleotide of claim 1 , wherein the mass-distinguishable product is amplified after its release from the detector oligonucleotide.

10. The detector oligonucleotide of claim 9 , wherein the detector oligonucleotide comprises a universal primer hybridization site and is amplified using a universal primer.

11. The detector oligonucleotide of claim 1 , wherein the non-complementary portion comprises a detection moiety.

12. The detector oligonucleotide of claim 1 that further comprises two or more of the modifications selected from the group consisting of minor groove binders, locked nucleic acids, amadites, capture mechanism, and detection moiety.

13. A library comprising two or more detector oligonucleotides of claim 1 , wherein each mass distinguishable product corresponds to a unique target nucleic acid.

14. The library of claim 13 which comprises 10 or more detector oligonucleotide species.

15. The library of claim 13 which comprises 50 or more detector oligonucleotide species.

16. The library of claim 13 which comprises 100 or more detector oligonucleotide species.

17. The library of claim 13 which comprises 250 or more detector oligonucleotide species.

Assignments (8)
SECURITY INTEREST Recorded Dec 10, 2021
From: AGENA BIOSCIENCE, INC.
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 058358/0661 →
RELEASE OF SECURITY INTEREST Recorded Dec 7, 2021
From: MIDCAP FUNDING IV TRUST
To: AGENA BIOSCIENCE, INC.
Reel/Frame 058741/0005 →
RELEASE OF SECURITY INTEREST IN REEL 041621 FRAME 0548 Recorded Jul 13, 2021
From: MIDCAP FINANCIAL TRUST
To: AGENA BIOSCIENCE, INC.
Reel/Frame 056860/0557 →
SECURITY INTEREST Recorded Mar 21, 2017
From: AGENA BIOSCIENCE, INC.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 042050/0888 →
SECURITY INTEREST Recorded Feb 3, 2017
From: AGENA BIOSCIENCE, INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 041621/0548 →
CHANGE OF NAME Recorded Jun 27, 2014
From: BIOSCIENCES ACQUISITION COMPANY
To: AGENA BIOSCIENCE, INC.
Reel/Frame 033248/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2014
From: SEQUENOM, INC.
To: BIOSCIENCES ACQUISITION COMPANY
Reel/Frame 033182/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2008
From: VAN DEN BOOM, DIRK JOHANNES; OETH, PAUL ANDREW; MAHBOUBI, PAYAM
To: SEQUENOM, INC.
Reel/Frame 021863/0517 →